[HTML][HTML] Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design

Q Qiao, X Liu, T Yang, K Cui, L Kong, C Yang… - … Pharmaceutica Sinica B, 2021 - Elsevier
Acute respiratory distress syndrome (ARDS) is characterized by the severe inflammation
and destruction of the lung air–blood barrier, leading to irreversible and substantial …

Nanomedicine-based therapeutics to combat acute lung injury

S Bian, H Cai, Y Cui, W Liu, C Xiao - International Journal of …, 2021 - Taylor & Francis
Acute lung injury (ALI) or its aggravated stage acute respiratory distress syndrome (ARDS)
may lead to a life-threatening form of respiratory failure, resulting in high mortality of up to 30 …

[HTML][HTML] Nanotechnology in pulmonary medicine

M Doroudian, A O'Neill, R Mac Loughlin… - Current opinion in …, 2021 - Elsevier
Nanotechnology in medicine—nanomedicine—is extensively employed to diagnose, treat,
and prevent pulmonary diseases. Over the last few years, this brave new world has made …

[HTML][HTML] Recent applications and strategies in nanotechnology for lung diseases

W Zhong, X Zhang, Y Zeng, D Lin, J Wu - Nano Research, 2021 - Springer
Lung diseases, including COVID-19 and lung cancers, is a huge threat to human health.
However, for the treatment and diagnosis of various lung diseases, such as pneumonia …

Hybrid biomimetic nanovesicles to drive high lung biodistribution and prevent cytokine storm for ARDS treatment

Q Qiao, X Liu, K Cui, X Li, T Tian, Y Yu, B Niu, L Kong… - ACS …, 2022 - ACS Publications
Acute respiratory distress syndrome (ARDS) has been a life threat for patients in ICUs. Vast
efforts have been devoted, while no medication has proved viable, which may be ascribed to …

Potential immuno-nanomedicine strategies to fight COVID-19 like pulmonary infections

SR Bonam, NG Kotla, RA Bohara, Y Rochev… - Nano today, 2021 - Elsevier
Abstract COVID-19, coronavirus disease 2019, caused by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has become a pandemic. At the time of writing this …

[HTML][HTML] Recent advances in nanoparticle applications in respiratory disorders: a review

ME Taghavizadeh Yazdi, M Qayoomian… - Frontiers in …, 2023 - frontiersin.org
Various nanoparticles are used in the discovery of new nanomedicine to overcome the
shortages of conventional drugs. Therefore, this article presents a comprehensive and up-to …

Clinical applications of nanomedicines in lung cancer treatment

M Norouzi, P Hardy - Acta biomaterialia, 2021 - Elsevier
Lung cancer is the leading cause of cancer mortality worldwide. Owing to a lack of early-
stage diagnosis, most lung cancers are detected in advanced stages, limiting the available …

[HTML][HTML] Advanced therapeutic strategies for chronic lung disease using nanoparticle-based drug delivery

JY Yhee, J Im, RS Nho - Journal of clinical medicine, 2016 - mdpi.com
Chronic lung diseases include a variety of obstinate and fatal diseases, including asthma,
chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), idiopathic pulmonary …

[HTML][HTML] Current approaches of nanomedicines in the market and various stage of clinical translation

X Shan, X Gong, J Li, J Wen, Y Li, Z Zhang - Acta Pharmaceutica Sinica B, 2022 - Elsevier
Compared with traditional drug therapy, nanomedicines exhibit intriguing biological features
to increase therapeutic efficiency, reduce toxicity and achieve targeting delivery. This review …